From: Plasminogen activator inhibitor (PAI-1) gene polymorphism (4G/5G) and hepatocellular carcinoma in Egyptian patients
HCC patients
Control
p value
Age (years)
Mean ± SD
55.7 ± 6.7
42.6 ± 7.4
< 0.001*a
Range
40–76
25–57
Sex
Male
36 (76.6%)
36 (72.0%)
0.605b
Female
11 (23.4%)
14 (28.0%)